Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2012-12-05Clinical Trial Update: Cisplatinum/Pemetrexed Versus Split-dose Cisplatinum/Pemetrexed In NSCLC [Phase 2]
A Phase 2 clinical trial compares cisplatin/pemetrexed with split-dose cisplatin/pemetrexed in non-small cell lung cancer; current status is…
-
CLINICAL_TRIALS trial_result · 2012-12-04Clinical Trial Update: Zometa Adjuvant Treatment of Malignant Pleural Effusion Due To Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating zoledronic acid (Zometa) as adjuvant treatment for malignant pleural effusion due to non-small cell lung cancer was…
-
CLINICAL_TRIALS trial_result · 2012-11-30Clinical Trial Update: Phase II Study of Docetaxel + ZD1839 in Elderly Patients With Non-Small Cell Lung Cancer [Phase 2]
Phase II study evaluating the combination of docetaxel and gefitinib (ZD1839) in elderly patients with non-small cell lung cancer; results o…
-
CLINICAL_TRIALS trial_result · 2012-11-28Clinical Trial Update: Sorafenib in Treating Patients With Refractory Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial investigating sorafenib in patients with refractory non-small cell lung cancer has completed with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-11-27Clinical Trial Update: A Study of Pemetrexed Plus Carboplatin, or Pemetrexed Plus Cisplatin With Radiation Therapy Followed by Pemetrexed in Patients With Inoperable Non-Small-Cell Lung Cancer [Phase 1, Phase 2]
A Phase 1/2 study evaluating pemetrexed with either carboplatin or cisplatin plus radiation therapy followed by pemetrexed in patients with …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-11-21Clinical Trial Update: A Phase 2 Study of Tarceva for Untreated, Good Prognosis Patients With Advanced Non-Small Cell Lung Cancer [Phase 2]
Phase 2 results for Tarceva (erlotinib) in untreated, good-prognosis patients with advanced non-small cell lung cancer have been posted. The…
-
CLINICAL_TRIALS research · 2012-11-15Clinical Trial Update: e- Ab Sensor-based Real-time Detection of Mutant EGFR in Clinical Specimens From Patients of Non-small Cell Lung Cancer [NA]
This clinical trial update describes a sensor-based method for real-time detection of mutant EGFR in clinical specimens from patients with n…
-
CLINICAL_TRIALS trial_result · 2012-11-14Clinical Trial Update: Pilot Study of Preoperative Tarceva (Erlotinib) for Stages I/II Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 pilot study evaluated preoperative Erlotinib (Tarceva) in patients with stages I/II non-small cell lung cancer; results have been …
-
FDA approval · 2012-11-13FDA Approved: CISPLATIN — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for cisplatin filed by Fresenius Kabi USA, LLC. This action confirms the continued approval of cispl…
-
CLINICAL_TRIALS trial_result · 2012-11-13Clinical Trial Update: Gemcitabine, Docetaxel, and Cetuximab in Patients With Unresectable Advanced Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluated the combination of gemcitabine, docetaxel, and cetuximab in patients with unresectable advanced non-small cell lun…
-
CLINICAL_TRIALS trial_result · 2012-11-13Clinical Trial Update: Pemetrexed and Gemcitabine in Patients With Advanced Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial update examining pemetrexed and gemcitabine in patients with advanced non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2012-11-13Clinical Trial Update: Preoperative Therapy in Patients With Stages IB, II, IIIA, and Selected IIIB Patients With Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating preoperative therapy in patients with stages I to IIIA (and selected IIIB) non-small cell lung cancer has complet…
-
CLINICAL_TRIALS trial_result · 2012-11-12Clinical Trial Update: A Study of the IGF-1R Inhibitor AXL1717 in Combination With Gemcitabine HCL and Carboplatin to Treat Non-small-cell Lung Cancer (NSCLC) [Phase 1]
This ClinicalTrials.gov update reports a Phase 1 study evaluating the IGF-1R inhibitor AXL1717 in combination with gemcitabine and carboplat…
-
CLINICAL_TRIALS trial_result · 2012-11-06Clinical Trial Update: A Study of Pegylated rhG-CSF as Support to Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy Receiving Chemotherapy [Phase 3]
Phase 3 study of pegylated rhG-CSF as support for advanced non-small cell lung cancer patients undergoing chemotherapy; trial status is curr…
-
CLINICAL_TRIALS research · 2012-11-06Clinical Trial Update: Observational Study to Characterize the Incidence of EGFR Mutation Positive and Advanced NSCLC Patients
This document describes an observational study aimed at characterizing how often EGFR-mutant disease occurs among patients with advanced non…
-
CLINICAL_TRIALS trial_result · 2012-11-01Clinical Trial Update: S0342: Paclitaxel, Carboplatin, and Cetuximab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial update evaluating the combination of paclitaxel, carboplatin, and cetuximab in stage IIIB or stage IV non-small cell …
-
CLINICAL_TRIALS trial_result · 2012-11-01Clinical Trial Update: The Effect of Docetaxel or Gemcitabine-based Chemotherapy in East Asian and Caucasian Patients [Phase 2]
Phase 2 trial comparing docetaxel- and gemcitabine-based chemotherapy in East Asian and Caucasian patients with non-small cell lung cancer o…
-
CLINICAL_TRIALS trial_result · 2012-11-01Clinical Trial Update: S0526: Pemetrexed Disodium in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer [Phase 2]
Phase 2 study S0526 evaluated pemetrexed disodium in patients with stage III or stage IV non-small cell lung cancer. The trial was terminate…
-
CLINICAL_TRIALS research · 2012-11-01Clinical Trial Update: Endobronchial Ultrasound- Transbronchial Needle Aspiration (EBUS-TBNA) Versus Mediastinoscopy for Mediastinal Lymph Node Staging of Non-small Cell Lung Cancer (NSCLC) [NA]
This clinical trial update reports a completed study comparing endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) …
-
CLINICAL_TRIALS trial_result · 2012-10-31Clinical Trial Update: Neoadjuvant IRESSA As Single Agent PreopTherapy for NSCLC With Molecular Correlates [NA]
This document reports a terminated neoadjuvant trial of gefitinib (IRESSA) as a single-agent preoperative therapy for non-small cell lung ca…
-
CLINICAL_TRIALS trial_result · 2012-10-30Clinical Trial Update: Study of Erlotinib With Docetaxel in Selected Non Small Cell Lung Cancer Patients in First Line Treatment [Phase 2]
Phase 2 trial evaluating the combination of erlotinib and docetaxel as first-line therapy for selected non-small cell lung cancer patients h…
-
CLINICAL_TRIALS trial_result · 2012-10-30Clinical Trial Update: Combined Modality Therapy With Growth Factor Support in Locally Advanced Non-small Cell Lung Cancer (NSCLC) [Phase 2]
This document reports the completion of a Phase 2 trial evaluating combined modality therapy with growth factor support in unresectable loca…
-
CLINICAL_TRIALS trial_result · 2012-10-26Clinical Trial Update: 131I-L19SIP Radioimmunotherapy Combined With Radiochemotherapy in Patients With Locally-advanced Non Small Cell Lung Cancer (NSCLC) [Phase 1]
Phase 1 trial evaluating 131I-L19SIP radioimmunotherapy combined with radiochemotherapy in locally advanced non-small cell lung cancer; the …
-
CLINICAL_TRIALS trial_result · 2012-10-22Clinical Trial Update: CPT-11/Cisplatin and Celecoxib With Radiation Therapy for Patients With Unresectable Non-Small Cell Lung Cancer (NSCLC) [Phase 1]
Phase 1 trial evaluating irinotecan (CPT-11), cisplatin, and celecoxib with radiation therapy in unresectable non-small cell lung cancer has…
-
CLINICAL_TRIALS trial_result · 2012-10-19Clinical Trial Update: Study of Oral Vinorelbine and Erlotinib in Non-Small Cell Lung Cancer [Phase 1]
Phase 1 study evaluating oral vinorelbine with erlotinib in Non-Small Cell Lung Cancer has completed.